Overview

Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effects of tacrolimus sustained-release capsules replacing cyclosporin on kidney function of renal transplant recipients.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma China, Inc.
Treatments:
Cyclosporine
Cyclosporins
Tacrolimus